☆ 4.6 Review

The Power of Extracellular Vesicles in Myeloproliferative Neoplasms: Crafting a Microenvironment That Matters

CELLS (2021)

Related references

Note: Only part of the references are listed.

Review Hematology

A provider's guide to primary myelofibrosis: pathophysiology, diagnosis, and management

Benjamin Garmezy et al.

Summary: Treatment options for primary myelofibrosis are limited, but diagnosis can often be established through appropriate clinical history, examination, laboratory evaluation, and bone marrow biopsy. Recent studies have characterized prognostic factors and driver mutations better, leading to the development of treatment strategies based on risk factors and clinical phenotype.

BLOOD REVIEWS (2021)

Add to Collection

Review Hematology

Is there a gender effect in polycythemia vera?

Francesca Palandri et al.

Summary: In recent years, there has been a growing interest in understanding the impact of gender on disease biology and clinical outcomes in Philadelphia-negative chronic myeloproliferative neoplasms, specifically polycythemia vera. This research aims to summarize data on how female sex can affect the biology and outcomes of PV, covering pathogenesis, diagnosis, epidemiology, clinical presentation, symptoms burden, thrombotic risk, treatment strategies, and prognosis in female patients.

ANNALS OF HEMATOLOGY (2021)

Add to Collection

Article Hematology

Primary myelofibrosis: 2021 update on diagnosis, risk-stratification and management

Ayalew Tefferi

Summary: Primary myelofibrosis (PMF) is a myeloproliferative neoplasm characterized by stem cell-derived clonal myeloproliferation, with common features including bone marrow fibrosis, abnormal inflammatory cytokine expression, anemia, hepatosplenomegaly, etc. Diagnosis is primarily based on bone marrow morphology. Treatment strategies can vary based on risk stratification, with options such as observation, drug therapy, or hematopoietic stem cell transplant.

AMERICAN JOURNAL OF HEMATOLOGY (2021)

Add to Collection

Article Cell Biology

Differential expression of circular RNAs in bone marrow-derived exosomes from essential thrombocythemia patients

Qiang Wang et al.

Summary: This study identified significant alterations in circRNA profiles in bone marrow-derived exosomes from ET patients, including downregulation of circDAP3, circASXL1, and circRUNX1. Moreover, circRNA-encoding genes and miRNA-mRNA networks targeted by these circRNAs were associated with various biological processes and signaling pathways, suggesting their potential role in ET pathogenesis. Additionally, circ_0014614 was found to inhibit the differentiation of K562 cells into megakaryocytes, indicating a possible mechanism for circRNA-based ET diagnosis and treatment.

CELL BIOLOGY INTERNATIONAL (2021)

Add to Collection

Article Oncology

The Microenvironment in Myeloproliferative Neoplasms

Gajalakshmi Ramanathan et al.

HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2021)

Add to Collection

Article Oncology

Epidemiology of the Philadelphia Chromosome-Negative Classical Myeloproliferative Neoplasms

Rory M. Shallis et al.

HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2021)

Add to Collection

Article Oncology

Thrombotic, Vascular, and Bleeding Complications of the Myeloproliferative Neoplasms

Andrew Schafer

HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2021)

Add to Collection

Article Oncology

The Role of Megakaryocytes in Myelofibrosis

Johanna Melo-Cardenas et al.

HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2021)

Add to Collection

Review Oncology

Clinical relevance of extracellular vesicles in hematological neoplasms: from liquid biopsy to cell biopsy

Stefania Trino et al.

Summary: Liquid biopsy is becoming increasingly important in oncology within the era of precision medicine, allowing for the isolation and analysis of tumor-derived biomarkers such as extracellular vesicles (EVs) in body fluids. EVs, as lipid bilayer-enclosed particles, have emerged as valuable carriers of cancer information, offering potential as novel biomarkers due to their molecular cargo mirroring parental cell characteristics. The translation of these new diagnostic tools into clinical practice has the potential to deeply revolutionize the field of cancer research.

LEUKEMIA (2021)

Add to Collection

Review Biochemistry & Molecular Biology

Inflammatory Microenvironment and Specific T Cells in Myeloproliferative Neoplasms: Immunopathogenesis and Novel Immunotherapies

Vincenzo Nasillo et al.

Summary: The immune dysregulation plays a significant role in the pathogenesis and development of MPNs, with detrimental cytokine milieu, expansion and altered functions of immune cells. MPNs can evade T cell immune surveillance through the PD-1/PD-L1 axis.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Add to Collection

Review Biochemistry & Molecular Biology

Sex-Related Differences in Chronic Myeloid Neoplasms: From the Clinical Observation to the Underlying Biology

Theodoros Karantanos et al.

Summary: Men with chronic myeloid neoplasms have overall worse survival and higher incidence of transformation to acute leukemia, with a male predominance for mutations in high-risk genes. Current research on the genomic profile and sex-related differences in patients with chronic myeloid neoplasms is ongoing, with further investigation needed into the hypothesized biological mechanisms.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Add to Collection

Article Oncology

Distinct profile of CD34+ cells and plasma-derived extracellular vesicles from triple-negative patients with Myelofibrosis reveals potential markers of aggressive disease

Dorian Forte et al.

Summary: In this study, it was found that the absolute numbers of circulating CD34(+) cells were significantly increased in triple-negative (TN) myelofibrosis patients. These cells displayed in vitro defective functions and were unresponsive to the inflammatory microenvironment. Furthermore, the circulating extracellular vesicles (EVs) from TN patients were found to promote the survival of TN CD34(+) cells, suggesting a distinct EV-driven signal promoting malignant hemopoiesis in TN patients. The distinct gene expression profiling analysis and microRNA signature in TN patients may provide insights for novel therapeutic approaches for this rare form of myelofibrosis.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2021)

Add to Collection

Review Oncology

Pathogenesis of cardiovascular events in BCR-ABL1-negative myeloproliferative neoplasms

Alexandre Guy et al.

Summary: Thrombosis is a major complication of myeloproliferative neoplasms, with risk factors including age, thrombosis history, and various complex mechanisms involving blood cell types, plasma factors, and endothelial cells. Additional cardiovascular events may stem from arterial vasospasm. Potential promising therapeutic targets not currently focused on include neutrophil extracellular traps and vascular reactivity.

LEUKEMIA (2021)

Add to Collection

Review Hematology

Polycythaemia vera: molecular genetics, diagnostics and therapeutics

Jeffrey S. Putter et al.

Summary: Polycythaemia vera is a myeloproliferative neoplasm linked to genetic mutations, which cause an elevation in red cell mass. Concepts from genetics and immunology help define the disease's origin and behavior, while the World Health Organization's diagnostic criteria focus on subtle distinctions and treatment options.

VOX SANGUINIS (2021)

Add to Collection

Review Oncology

A Broad Overview of Signaling in Ph-Negative Classic Myeloproliferative Neoplasms

Ana Guijarro-Hernandez et al.

Summary: There is growing evidence that Ph-negative myeloproliferative neoplasms are disorders in which multiple signaling pathways are significantly disturbed. The discovery of somatic mutations in JAK2, MPL, and CALR has shed light on the aberrant functions of their mutant products, while additional somatic mutations in other genes have added complexity to the molecular pathogenesis of MPNs. This review highlights the involvement of a wide variety of cellular processes and pathways in the pathogenesis of MPNs, explaining their phenotypic heterogeneity.

CANCERS (2021)

Add to Collection

Review Oncology

Evaluation of Therapeutic Strategies to Reduce the Number of Thrombotic Events in Patients With Polycythemia Vera and Essential Thrombocythemia

Douglas Tremblay et al.

Summary: Thrombosis is a major cause of morbidity and mortality in patients with polycythemia vera and essential thrombocythemia. Current understanding of the risk factors and pathophysiology of thrombosis in these patients is growing, though few therapies have shown effectiveness in reducing thrombotic burden. More studies are needed to evaluate the impact of therapeutic agents on thrombotic events in these myeloproliferative neoplasms.

FRONTIERS IN ONCOLOGY (2021)

Add to Collection

Article Hematology

Patients with triple-negative, JAK2V617F- and CALR-mutated essential thrombocythemia share a unique gene expression signature

Samah Alimam et al.

Summary: The study identified similar patterns of gene expression and DNA methylation in patients with essential thrombocythemia (ET) with known driver mutations and those with triple-negative disease, suggesting that the ET phenotype may be primarily driven by transcriptional misregulation and may propagate downstream via MAPK, tumor necrosis factor, and NF kappa B pathways. These findings highlight potential novel mechanisms of disease initiation that require further evaluation.

BLOOD ADVANCES (2021)

Add to Collection

Review Cell Biology

Exosomes: Isolation, characterization, and biomedical applications

Ghadi N. Alzhrani et al.

Summary: Exosomes are nano-sized bioactive vesicles secreted by most cell types into extracellular fluid, containing lipids, proteins, and nucleic acid that regulate intracellular communication between cells. Due to their desirable features, exosomes have shown promise in therapeutic applications and diagnostic tools in biomedical fields. Various techniques for isolating, purifying, and characterizing exosomes from biological fluids and cell cultures were discussed in this review.

CELL BIOLOGY INTERNATIONAL (2021)

Add to Collection

Review Cell Biology

The exosome journey: from biogenesis to uptake and intracellular signalling

Sonam Gurung et al.

Summary: Exosomes have vast potential in clinical applications, and understanding their biology is crucial. The processes of exosome biogenesis, transport, and uptake involve numerous influencing factors.

CELL COMMUNICATION AND SIGNALING (2021)

Add to Collection

Article Oncology

Current Clinical Investigations in Myelofibrosis

Sangeetha Venugopal et al.

HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2021)

Add to Collection

Article Oncology

Genetics of Myeloproliferative Neoplasms

Jakub Szybinski et al.

Summary: Phenotypic driver mutations in JAK2, calreticulin, and MPL are common in myeloproliferative neoplasms and additional genetic alterations are mainly found in epigenetic modifiers and splicing factors. As the disease progresses, these genetic alterations undergo clonal evolution, with high molecular risk mutations impacting disease dynamics and outcomes. Understanding the genetic basis facilitates diagnosis, prognosis, and identifies new candidates for targeted therapy.

HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2021)

Add to Collection

Article Oncology

Unmet Need in Essential Thrombocythemia and Polycythemia Vera

Ashwin Kishtagari et al.

HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2021)

Add to Collection

Review Cell Biology

CircRNAs: role in human diseases and potential use as biomarkers

Lorena Verduci et al.

Summary: Circular RNAs (circRNAs) are a unique class of endogenous RNAs characterized by a covalent loop structure, high stability, and tissue specificity. Their main mode of action is sponging microRNAs, but they may also have the ability to bind specific proteins and encode short proteins. CircRNAs play various functional roles in human diseases, serving as potential biomarkers due to their stable nature and remarkable tissue specificity.

CELL DEATH & DISEASE (2021)

Add to Collection

Review Oncology

Novel Pathophysiological Mechanisms of Thrombosis in Myeloproliferative Neoplasms

Brandi N. Reeves et al.

Summary: The main cause of thrombosis in MPN patients is the increased quantity and abnormal quality of circulating blood cells, leading to a higher thrombotic risk. Recent studies have shown that thrombo-inflammatory genes are upregulated in JAK2(V617F) granulocytes and platelets. Additionally, red blood cells, platelets, and the vasculature may also contribute to thrombosis through various mechanisms.

CURRENT HEMATOLOGIC MALIGNANCY REPORTS (2021)

Add to Collection

Review Pharmacology & Pharmacy

Role of ATP in Extracellular Vesicle Biogenesis and Dynamics

Marta Lombardi et al.

Summary: ATP serves as a danger signal in the immune response by activating P2X and P2Y receptors to promote inflammation, with the P2X7 receptor being a critical player. ATP stimulation leads to cell proliferation, inflammasome activation, and extracellular vesicle release, which can transfer molecules to target cells. This review discusses the role of ATP in the biogenesis and dynamics of extracellular vesicles, highlighting their important functions in physiology and pathophysiology.

FRONTIERS IN PHARMACOLOGY (2021)

Add to Collection

Review Genetics & Heredity

The Vesicular Intelligence Strategy of Blood Cancers

Dorian Forte et al.

Summary: Blood cancers, including leukemia, multiple myeloma, and lymphoma, can originate from clonal evolution of stem cells or transformation of immune progenitors. Extracellular vesicles (EVs) play a significant role in cancer by delivering molecules to influence target cells. The 'vesicular intelligence' strategy used by blood cancers through EVs promotes malignant clone development and maintenance.

GENES (2021)

Add to Collection

Review Cell Biology

The role of lipids in exosome biology and intercellular communication: Function, analytics and applications

Javier Donoso-Quezada et al.

Summary: Exosomes are important extracellular vesicles with compositions related to the progression of various diseases. Lipids, as crucial components of exosomes, play significant roles in exosome biology and intercellular communication. Exosome lipidomics is an emerging discipline that offers insights into the discovery of new lipid species for biomedical applications.

TRAFFIC (2021)

Add to Collection

Review Immunology

Inflammatory Pathophysiology as a Contributor to Myeloproliferative Neoplasms

Daniel Arthur Corpuz Fisher et al.

Summary: Myeloid neoplasms such as AML, MPNs, and MDS involve clonal dominance and remodeling of bone marrow niche leading to malignant hematopoiesis. Inflammatory signaling hyperactivation and cytokine overproduction play critical roles, with cytokines like TNF potentially contributing to malignant clonal dominance. Targeting cytokine-mediated signaling may be a promising therapeutic strategy.

FRONTIERS IN IMMUNOLOGY (2021)

Add to Collection

Review Biochemistry & Molecular Biology

The ins and outs of microvesicles

James W. Clancy et al.

Summary: Microvesicles are a heterogeneous group of membrane-enclosed vesicles released from cells, carrying selectively sorted proteins and nucleic acids. Despite increasing interest in the clinical potential of microvesicles, limited understanding exists on different types and formation mechanisms of microvesicles.

FASEB BIOADVANCES (2021)

Add to Collection

Review Hematology

Functional Consequences of Mutations in Myeloproliferative Neoplasms

Stefan N. Constantinescu et al.

Summary: Driver mutations in JAK2, CALR, and MPL play crucial roles in BCR-ABL1 negative MPNs, leading to persistent JAK2-STAT5 activation. Epigenetic mutations coexist in 35%-40% of MPNs, promoting clonal hematopoiesis and increased fitness of hematopoietic stem cells. Understanding the interactions between driver mutations and epigenetic rewiring is essential for developing better therapeutic interventions for MPNs.

HEMASPHERE (2021)

Add to Collection

Review Hematology

Low-Risk Essential Thrombocythemia: A Comprehensive Review

Andrew J. Robinson et al.

Summary: Essential thrombocythemia is a chronic myeloproliferative neoplasm characterized by persistently elevated platelet count, requiring treatment based on individual risk assessment. The diagnostic pathway includes molecular investigations and bone marrow biopsy, while risk stratification is crucial for guiding treatment decisions.

HEMASPHERE (2021)

Add to Collection

Review Biochemistry & Molecular Biology

Large extracellular vesicles: Size matters in tumor progression

Chiara Ciardiello et al.

CYTOKINE & GROWTH FACTOR REVIEWS (2020)

Add to Collection

Review Hematology

Myelofibrosis biology and contemporary management

Naseema Gangat et al.

BRITISH JOURNAL OF HAEMATOLOGY (2020)

Add to Collection

Article Medicine, Research & Experimental

Erythrocyte-derived microvesicles induce arterial spasms in JAK2V617F myeloproliferative neoplasm

Johanne Poisson et al.

JOURNAL OF CLINICAL INVESTIGATION (2020)

Add to Collection

Article Hematology

Increased CXCL4 expression in hematopoietic cells links inflammation and progression of bone marrow fibrosis in MPN

Helene F. E. Gleitz et al.

BLOOD (2020)

Add to Collection

Article Hematology

Polycythemia vera and essential thrombocythemia: 2021 update on diagnosis, risk-stratification and management

Ayalew Tefferi et al.

AMERICAN JOURNAL OF HEMATOLOGY (2020)

Add to Collection

Review Biochemistry & Molecular Biology

Large Extracellular Vesicles-A New Frontier of Liquid Biopsy in Oncology

Gaetano Pezzicoli et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Add to Collection

Review Oncology

Extracellular microvesicles/exosomes: discovery, disbelief, acceptance, and the future?

Mariusz Z. Ratajczak et al.

LEUKEMIA (2020)

Add to Collection

Review Oncology

Risks of Solid and Lymphoid Malignancies in Patients with Myeloproliferative Neoplasms: Clinical Implications

Mette Brabrand et al.

CANCERS (2020)

Add to Collection

Review Cell Biology

Cytokine Profiling in Myeloproliferative Neoplasms: Overview on Phenotype Correlation, Outcome Prediction, and Role of Genetic Variants

Elena Masselli et al.

CELLS (2020)

Add to Collection

Review Cell Biology

Uptake and Fate of Extracellular Membrane Vesicles: Nucleoplasmic Reticulum-Associated Late Endosomes as a New Gate to Intercellular Communication

Denis Corbeil et al.

CELLS (2020)

Add to Collection

Review Medicine, Research & Experimental

Communication between stromal and hematopoietic stem cell by exosomes in normal and malignant bone marrow niche

Vahid Niazi et al.

BIOMEDICINE & PHARMACOTHERAPY (2020)

Add to Collection

Review Biochemistry & Molecular Biology

The Genetic Basis of Primary Myelofibrosis and Its Clinical Relevance

Elisa Rumi et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Add to Collection

Review Biotechnology & Applied Microbiology

Impact of Mutational Profile on the Management of Myeloproliferative Neoplasms: A Short Review of the Emerging Data

Giuseppe G. Loscocco et al.

ONCOTARGETS AND THERAPY (2020)

Add to Collection

Article Oncology

The role of circulating monocytes and JAK inhibition in the infectious-driven inflammatory response of myelofibrosis

Martina Barone et al.

ONCOIMMUNOLOGY (2020)

Add to Collection

Review Biochemistry & Molecular Biology

High-throughput analysis and functional interpretation of extracellular vesicle content in hematological malignancies

Ilaria Tanasi et al.

COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2020)

Add to Collection

Article Oncology

Cytokine production in myelofibrosis exhibits differential responsiveness to JAK-STAT, MAP kinase, and NFκB signaling

Daniel A. C. Fisher et al.

LEUKEMIA (2019)

Add to Collection

Editorial Material Medicine, General & Internal

Reprogramming of GBM microenvironment by large oncosomes: 'Traveling' V-ATPases are doing more than acidification

Delphine Garnier

EBIOMEDICINE (2019)

Add to Collection

Review Cell Biology

New insights into extracellular vesicle biogenesis and function

Arash Latifkar et al.

JOURNAL OF CELL SCIENCE (2019)

Add to Collection

Article Oncology

Large oncosomes overexpressing integrin alpha-V promote prostate cancer adhesion and invasion via AKT activation

Chiara Ciardiello et al.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)

Add to Collection

Article Oncology

Immune Checkpoint Blockade Enhances Shared Neoantigen-Induced T-cell Immunity Directed against Mutated Calreticulin in Myeloproliferative Neoplasmas

Cansu Cimen Bozkus et al.

CANCER DISCOVERY (2019)

Add to Collection

Article Medicine, General & Internal

Essential Thrombocythemia

Ayalew Tefferi et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

Add to Collection

Article Hematology

Polycythemia vera and essential thrombocythemia: 2019 update on diagnosis, risk-stratification and management

Ayalew Tefferi et al.

AMERICAN JOURNAL OF HEMATOLOGY (2019)

Add to Collection

Article Cell Biology

Biological membranes in EV biogenesis, stability, uptake, and cargo transfer: an ISEV position paper arising from the ISEV membranes and EVs workshop

Ashley E. Russell et al.

JOURNAL OF EXTRACELLULAR VESICLES (2019)

Add to Collection

Letter Hematology

Circulating megakaryocyte and platelet microvesicles correlate with response to ruxolitinib and distinct disease severity in patients with myelofibrosis

Martina Barone et al.

BRITISH JOURNAL OF HAEMATOLOGY (2019)

Add to Collection

Article Biochemical Research Methods

Quantitative Proteomic Analysis of Small and Large Extracellular Vesicles (EVs) Reveals Enrichment of Adhesion Proteins in Small EVs

Lizandra Jimenez et al.

JOURNAL OF PROTEOME RESEARCH (2019)

Add to Collection

Letter Oncology

Young versus old age at diagnosis confers distinct genomic profiles in patients with polycythemia vera

Jared S. Fowles et al.

LEUKEMIA (2019)

Add to Collection

Article Biochemistry & Molecular Biology

Comparison of Proteome Composition of Serum Enriched in Extracellular Vesicles Isolated from Polycythemia Vera Patients and Healthy Controls

Anna Fel et al.

PROTEOMES (2019)

Add to Collection

Article Hematology

Defective negative regulation of Toll-like receptor signaling leads to excessive TNF-α in myeloproliferative neoplasm

Hew Yeng Lai et al.

BLOOD ADVANCES (2019)

Add to Collection

Review Cell Biology

Basics and applications of tumor-derived extracellular vesicles

Yu-Ling Tai et al.

JOURNAL OF BIOMEDICAL SCIENCE (2019)

Add to Collection

Article Oncology

The calreticulin (CALR) exon 9 mutations are promising targets for cancer immune therapy

M. O. Holmstrom et al.

LEUKEMIA (2018)

Add to Collection

Review Hematology

Extracellular vesicles in the hematopoietic microenvironment

John T. Butler et al.

HAEMATOLOGICA (2018)

Add to Collection

Review Hematology

Extracellular vesicles in the hematopoietic microenvironment

John T. Butler et al.

HAEMATOLOGICA (2018)

Add to Collection

Review Cell & Tissue Engineering

Extracellular Vesicles: A New Prospective in Crosstalk between Microenvironment and Stem Cells in Hematological Malignancies

Ilaria Laurenzana et al.

STEM CELLS INTERNATIONAL (2018)

Add to Collection

Article Hematology

The JAK2V617F Point Mutation Increases the Osteoclast Forming Ability of Monocytes in Patients with Chronic Myeloproliferative Neoplasms and Makes their Osteoclasts more Susceptible to JAK2 Inhibition

Emmanouil Spanoudakis et al.

MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES (2018)

Add to Collection

Article Oncology

Philadelphia-negative myeloproliferative neoplasms as disorders marked by cytokine modulation

Maira da Costa Cacemiro et al.

HEMATOLOGY TRANSFUSION AND CELL THERAPY (2018)

Add to Collection

Article Cell Biology

Large extracellular vesicles carry most of the tumour DNA circulating in prostate cancer patient plasma

Tatyana Vagner et al.

JOURNAL OF EXTRACELLULAR VESICLES (2018)

Add to Collection

Article Hematology

Myeloid malignancies and the microenvironment

Claudia Korn et al.

BLOOD (2017)

Add to Collection

Letter Oncology

The JAK2V617F mutation is a target for specific T cells in the JAK2V617F-positive myeloproliferative neoplasms

M. O. Holmstrom et al.

LEUKEMIA (2017)

Add to Collection

Article Hematology

Elevated plasma levels of procoagulant microparticles are a novel risk factor for thrombosis in patients with myeloproliferative neoplasms

Yasuhiro Taniguchi et al.

INTERNATIONAL JOURNAL OF HEMATOLOGY (2017)

Add to Collection

Article Medical Laboratory Technology

Observational retrospective study of vascular modulator changes during treatment in essential thrombocythemia

Andrea Piccin et al.

TRANSLATIONAL RESEARCH (2017)

Add to Collection

Article Oncology

Clinical significance of circulating microparticles in Ph-myeloproliferative neoplasms

Wenjuan Zhang et al.

ONCOLOGY LETTERS (2017)

Add to Collection

Article Oncology

Risk factors for arterial versus venous thrombosis in polycythemia vera: a single center experience in 587 patients

S. Cerquozzi et al.

BLOOD CANCER JOURNAL (2017)

Add to Collection

Article Oncology

Mutations in JAK2 and Calreticulin genes are associated with specific alterations of the immune system in myelofibrosis

Marco Romano et al.

ONCOIMMUNOLOGY (2017)

Add to Collection

Article Hematology

Monocytosis in polycythemia vera: Clinical and molecular correlates

Daniela Barraco et al.

AMERICAN JOURNAL OF HEMATOLOGY (2017)

Add to Collection

Article Oncology

MYC Mediates Large Oncosome-Induced Fibroblast Reprogramming in Prostate Cancer

Valentina R. Minciacchi et al.

CANCER RESEARCH (2017)

Add to Collection

Review Hematology

Myeloproliferative neoplasm stem cells

Adam J. Mead et al.

BLOOD (2017)

Add to Collection

Article Peripheral Vascular Disease

PML-RARa modulates the vascular signature of extracellular vesicles released by acute promyelocytic leukemia cells

Yi Fang et al.

ANGIOGENESIS (2016)

Add to Collection

Letter Hematology

Reduced frequency of circulating CD4+CD25brightCD127lowFOXP3+ regulatory T cells in primary myelofibrosis

Margherita Massa et al.

BLOOD (2016)

Add to Collection

Letter Hematology

Microparticle phenotypes are associated with driver mutations and distinct thrombotic risks in essential thrombocythemia

Agnes Charpentier et al.

HAEMATOLOGICA (2016)

Add to Collection

Letter Oncology

The CALR exon 9 mutations are shared neoantigens in patients with CALR mutant chronic myeloproliferative neoplasms

M. O. Holmstrom et al.

LEUKEMIA (2016)

Add to Collection

Review Oncology

Myeloproliferative neoplasms and inflammation: whether to target the malignant clone or the inflammatory process or both

S. Koschmieder et al.

LEUKEMIA (2016)

Add to Collection

Article Oncology

Myeloid-derived suppressor cells in patients with myeloproliferative neoplasm

Jen Chin Wang et al.

LEUKEMIA RESEARCH (2016)

Add to Collection

Letter Hematology

Microparticle phenotypes are associated with driver mutations and distinct thrombotic risks in essential thrombocythemia

Agnes Charpentier et al.

HAEMATOLOGICA (2016)

Add to Collection

Article Hematology

Targeted deep sequencing in polycythemia vera and essential thrombocythemia

Ayalew Tefferi et al.

BLOOD ADVANCES (2016)

Add to Collection

Article Hematology

Increasing procoagulant activity of circulating microparticles in patients with Philadelphia-negative myeloproliferative neoplasms: a single-centre experience

Jarmila Kissova et al.

BLOOD COAGULATION & FIBRINOLYSIS (2015)

Add to Collection

Article Immunology

Natural killer cells in patients with polycythemia vera

Carole Sanchez et al.

HUMAN IMMUNOLOGY (2015)

Add to Collection

Review Biochemical Research Methods

Mass-Spectrometry-Based Molecular Characterization of Extracellular Vesicles: Lipidomics and Proteomics

Simion Kreimer et al.

JOURNAL OF PROTEOME RESEARCH (2015)

Add to Collection

Review Cell Biology

Inflammation as a Driver of Clonal Evolution in Myeloproliferative Neoplasm

Angela G. Fleischman

MEDIATORS OF INFLAMMATION (2015)

Add to Collection

Editorial Material Biochemical Research Methods

Isolation and molecular characterization of extracellular vesicles

Douglas D. Taylor

METHODS (2015)

Add to Collection

Article Oncology

High serum levels of extracellular vesicles expressing malignancy-related markers are released in patients with various types of hematological neoplastic disorders

Antonella Caivano et al.

TUMOR BIOLOGY (2015)

Add to Collection

Article Hematology

Phospholipid-dependent procoagulant activity is highly expressed by circulating microparticles in patients with essential thrombocythemia

Marina Marchetti et al.

AMERICAN JOURNAL OF HEMATOLOGY (2014)

Add to Collection

Article Hematology

Cytokine profiles in polycythemia vera and essential thrombocythemia patients: Clinical implications

Emmanuel Pourcelot et al.

EXPERIMENTAL HEMATOLOGY (2014)

Add to Collection

Article Multidisciplinary Sciences

Neuropathy of haematopoietic stem cell niche is essential for myeloproliferative neoplasms

Lorena Arranz et al.

NATURE (2014)

Add to Collection

Article Oncology

An Immune Dysregulation in MPN

Giovanni Barosi

CURRENT HEMATOLOGIC MALIGNANCY REPORTS (2014)

Add to Collection

Article Cell Biology

Large oncosomes mediate intercellular transfer of functional microRNA

Matteo Morello et al.

CELL CYCLE (2013)

Add to Collection

Article Cell & Tissue Engineering

Myeloproliferative Neoplasia Remodels the Endosteal Bone Marrow Niche into a Self-Reinforcing Leukemic Niche

Koen Schepers et al.

CELL STEM CELL (2013)

Add to Collection

Article Medicine, General & Internal

Somatic CALR Mutations in Myeloproliferative Neoplasms with Nonmutated JAK2

J. Nangalia et al.

NEW ENGLAND JOURNAL OF MEDICINE (2013)

Add to Collection

Article Medicine, General & Internal

Somatic Mutations of Calreticulin in Myeloproliferative Neoplasms

Thorsten Klampfl et al.

NEW ENGLAND JOURNAL OF MEDICINE (2013)

Add to Collection

Article Hematology

Flow cytometry demonstrates differences in platelet reactivity and microparticle formation in subjects with thrombocytopenia or thrombocytosis due to primary haematological disorders

David E. Connor et al.

THROMBOSIS RESEARCH (2013)

Add to Collection

Article Hematology

Plasma cytokines in polycythemia vera: Phenotypic correlates, prognostic relevance, and comparison with myelofibrosis

Rakhee Vaidya et al.

AMERICAN JOURNAL OF HEMATOLOGY (2012)

Add to Collection

Article Hematology

Circulating levels of MCP-1, sIL-2R, IL-15, and IL-8 predict anemia response to pomalidomide therapy in myelofibrosis

Animesh Pardanani et al.

AMERICAN JOURNAL OF HEMATOLOGY (2011)

Add to Collection

Article Hematology

Increase in circulating CD4+CD25+Foxp3+ T cells in patients with Philadelphia-negative chronic myeloproliferative neoplasms during treatment with IFN-α

Caroline Hasselbalch Riley et al.

BLOOD (2011)

Add to Collection

Article Hematology

Inflammation and thrombosis in essential thrombocythemia and polycythemia vera: different role of C-reactive protein and pentraxin 3

Tiziano Barbui et al.

HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2011)

Add to Collection

Article Hematology

Blast-derived microvesicles in sera from patients with acute myeloid leukemia suppress natural killer cell function via membrane-associated transforming growth factor-β1

Miroslaw J. Szczepanski et al.

HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2011)

Add to Collection

Article Oncology

Circulating Interleukin (IL)-8, IL-2R, IL-12, and IL-15 Levels Are Independently Prognostic in Primary Myelofibrosis: A Comprehensive Cytokine Profiling Study

Ayalew Tefferi et al.

JOURNAL OF CLINICAL ONCOLOGY (2011)

Add to Collection

Article Hematology

Platelet- and Megakaryocyte-Derived Microparticles

Robert Flaumenhaft et al.

SEMINARS IN THROMBOSIS AND HEMOSTASIS (2010)

Add to Collection

Letter Hematology

Flow cytometry-evaluated platelet CD36 expression, reticulated platelets and platelet microparticles in essential thrombocythaemia and secondary thrombocytosis

Marie-Pierre Moles-Moreau et al.

THROMBOSIS RESEARCH (2010)

Add to Collection

Article Hematology

Increased circulating procoagulant activity and thrombin generation in patients with myeloproliferative neoplasms

Jerome Duchemin et al.

THROMBOSIS RESEARCH (2010)

Add to Collection

Article Hematology

Megakaryocyte-derived microparticles: direct visualization and distinction from platelet-derived microparticles

Robert Flaumenhaft et al.

BLOOD (2009)

Add to Collection

Article Hematology

Elevated procoagulant microparticles expressing endothelial and platelet markers in essential thrombocythemia

Marijke C. Trappenburg et al.

HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2009)

Add to Collection

Article Oncology

Monocytosis is an adverse prognostic factor for survival in younger patients with primary myelofibrosis

M. A. Elliott et al.

LEUKEMIA RESEARCH (2007)

Add to Collection

Article Hematology

MPL515 mutations in myeloproliferative and other myeloid disorders:: a study of 1182 patients

Animesh D. Pardanani et al.

BLOOD (2006)

Add to Collection

Article Hematology

Serum interleukin (IL)-1, IL-2, sIL-2Ra, IL-6 and thrombopoietin levels in patients with chronic myeloproliferative diseases

KE Panteli et al.

BRITISH JOURNAL OF HAEMATOLOGY (2005)

Add to Collection

Article Multidisciplinary Sciences

A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera

C James et al.

NATURE (2005)

Add to Collection

Article Medicine, General & Internal

A gain-of-function mutation of JAK2 in myeloproliferative disorders

R Kralovics et al.

NEW ENGLAND JOURNAL OF MEDICINE (2005)

Add to Collection

Article Immunology

Impaired NK cell differentiation of blood-derived CD34+ progenitors from patients with myeloid metaplasia with myelofibrosis

D Briard et al.

CLINICAL IMMUNOLOGY (2003)

Add to Collection

© Peeref 2019-2024. All rights reserved.